AstraZeneca inks pact with Research Society for Study of Diabetes in India
As a key facet of this association, the company has unveiled a three-year patient awareness programme, 'Beyond Sugar', developed to benefit over 1 crore people living with diabetes across the country, AstraZeneca India said in a statement.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: AstraZeneca | Biotechnology | Diabetes | Endocrinology | India Health | Pharmaceuticals | Study | Sugar